Spruce Biosciences operates under the executive leadership of Dr. Javier Szwarcberg, M.D., M.P.H., who serves as the Chief Executive Officer and Director. Bringing extensive physician-executive experience and specialized leadership backgrounds in clinical research and rare disease therapeutic development, he oversees the company's corporate strategy, regulatory interactions, and clinical pipeline execution.